PREvention of VENous ThromboEmbolism Following Radical Prostatectomy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 501 participants.

Also called NCT03006562

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 501 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03006562
Other papers using this trial's data
  • Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial European urology, 2020-09 DOI, PubMed 32444264

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT03006562. Randomized; single masking; primary purpose prevention. Start 2017-07-01 (actual); primary completion 2019-11-01 (actual). Results posted on 2020-02-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
Acronym
PREVENTER
Condition
Prostate Cancer
Condition
Venous Thromboembolism
Condition
Lymphocele After Surgical Procedure
Condition
Deep Venous Thrombosis
Intervention (Drug)
Subcutaneous Heparin
Lead sponsor
Johns Hopkins University (class: other)

Record details

Record id
cardio:ct-nct03006562
Content hash
0388d7e0f0585e674c3002f05a1f8b097c05a077159299a93c948f8bb9f16b72